Evidence map›Paper›PMID 36135740›Full record

ArticleMarine drugs2022

Ulvan-Based Nanofibrous Patches Enhance Wound Healing of Skin Trauma Resulting from Cryosurgical Treatment of Keloids.

Stefanos Kikionis, Marianna Koromvoki, Anna Tagka, Eleni Polichronaki, Alexandros Stratigos, Antonios Panagiotopoulos, Aikaterini Kyritsi, Vangelis Karalis, Andreas Vitsos, Michail Rallis and 2 more

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Stefanos KikionisSection of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0002-0599-7490
Marianna KoromvokiSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15784 Athens, Greece.ORCID 0000-0002-2073-3530
Anna TagkaFirst Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Syggros Hospital, 5 Ionos Dragoumi Str., 11621 Athens, Greece.
Eleni PolichronakiFirst Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Syggros Hospital, 5 Ionos Dragoumi Str., 11621 Athens, Greece.
Alexandros StratigosFirst Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Syggros Hospital, 5 Ionos Dragoumi Str., 11621 Athens, Greece.
Antonios PanagiotopoulosFirst Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Syggros Hospital, 5 Ionos Dragoumi Str., 11621 Athens, Greece.
Aikaterini KyritsiSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15784 Athens, Greece.ORCID 0000-0002-0605-9084
Vangelis KaralisSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15784 Athens, Greece.
Andreas VitsosSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15784 Athens, Greece.ORCID 0000-0002-2246-5381
Michail RallisSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15784 Athens, Greece.ORCID 0000-0002-3802-197X
Efstathia IoannouSection of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0003-3103-4951
Vassilios RoussisSection of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0001-9856-4725
National and Kapodistrian University of Athens · GR

Funding

General Secretariat for Research and Technology T1ΕΔΚ-00232
6 · The paper itself

Abstract

Keloids are skin fibroproliferative disorders, resulting from abnormal healing of deep cutaneous injuries. Cryosurgery, the most common treatment for keloids, causes skin traumas. Even though the clinical practice of cryosurgery has increased, effective wound healing therapy is still lacking. In this investigation, nonwoven nanofibrous patches composed of ulvan, a marine sulfated polysaccharide exhibiting anti-inflammatory and antioxidant activities, and polyethylene oxide (PEO) were fabricated through electrospinning and characterized. Their wound healing efficacy on skin traumas resulting from cryosurgical treatment of keloids was clinically tested and evaluated in comparison to a reference product. Twenty-four volunteer patients undergoing cryosurgery as a treatment of keloids were selected to apply either the ulvan/PEO patch or the reference product for 21 days. The ulvan/PEO patch, 21 days after cryosurgery, showed significant wound healing, elimination of skin inflammation, restoration of biophysical parameters similar to normal values and significant decrease in haemoglobin concentration, skin texture and volume, while no discomfort or adverse reaction was observed. In contrast, the reference product showed inferior performance in all evaluated parameters. The designed ulvan/PEO patch represents the first wound dressing to effectively heal skin trauma after cryosurgical treatment of keloids.

Indexed as

KeloidNanofibersSkin DiseasesAntioxidantsHemoglobinsHumansPolyethylene GlycolsPolysaccharidesWound HealingAntioxidantsHemoglobinsPolyethylene GlycolsPolysaccharidesulvancryosurgeryelectrospun nanofibrous patcheskeloidsulvanwound healing

Identifiers

PMID36135740
PMCPMC9505379
OpenAlexW4293758628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.